▟ Vinebot intrinsic value, daily

← back

VTR Ventas

reit · valued with opus medium conviction · deep-dived 2026-11-05

BUY
Intrinsic value$69.72
Price (at call)$89.20
Margin of safety -21.8%
vs market (rating basis) +22.2%

SHOP growth keeps compounding, but at 25x FFO the price already discounts the demographic boom.

The story

Ventas owns a senior housing, medical office and life science portfolio, and its senior housing operating portfolio (SHOP) is the growth engine. Occupancy gains and pricing power are flowing through as the 80+ population surges while new supply sits near cycle lows; revenue grew about 16% to 6.78B. The balance sheet is investment grade, and recent growth has been funded mainly with equity issued at a premium multiple. The stock is rate sensitive: at about 25x FFO (1.89B FFO against a 47.17B market cap), it trades like a growth asset whose multiple compresses if long yields rise.

I nudged year-1 growth from 11% to 12% because revenue accelerated about 16% and operating margin expanded again to 14.7%, confirming SHOP operating leverage. Capex of 0.77B is about 41% of FFO, but part of it is development and repositioning rather than maintenance, so I keep a 0.75 AFFO/FFO ratio to reflect SHOP's heavy recurring capex. Terminal growth stays at 3%, below the 4.89% risk-free rate, and beta stays at 0.85; the business is lower risk than the 0.9 industry anchor because of its demographic tailwind and strong balance sheet, but that is offset by operator and labor-cost exposure.

Value drivers

AFFO growth (Y1)12.0%
Terminal AFFO growth3.0%
AFFO / FFO ratio75.0%
Beta0.85
Failure probability0.4%
Cost of equity8.7%

Valuation bridge

PV of AFFO (explicit)14.35B
PV of terminal value22.67B
Equity value36.87B
÷ shares → per share$69.72

Projected AFFO

YrFFOAFFOGrowthPV
12.11B 1.58B12.0% 1.46B
22.34B 1.76B11.0% 1.49B
32.58B 1.93B10.0% 1.50B
42.81B 2.11B9.0% 1.51B
53.04B 2.28B8.0% 1.50B
63.25B 2.44B7.0% 1.48B
73.44B 2.58B6.0% 1.44B
83.61B 2.71B5.0% 1.39B
93.76B 2.82B4.0% 1.33B
103.87B 2.90B3.0% 1.26B

Key risks

  • Rising long-term rates compress the roughly 25x P/FFO multiple and raise the cost of equity issuance used to fund acquisitions
  • Senior housing construction restarts by 2028-2029 as current high returns attract new supply, capping occupancy and rent growth
  • Operator labor-cost inflation and tenant credit stress in the medical office and life science segments erode SHOP margins

Catalysts

  • SHOP occupancy moving into the high 80s with mid-single-digit rate increases, driving same-store NOI growth in the teens
  • Accretive SHOP acquisitions funded with premium-priced equity, plus Fed rate cuts that lower the discount rate

History

DatePriceIntrinsicMoSRating
2026-11-05$89.20 $69.72 -21.8% BUY
2026-09-24$86.64 $63.27 -27.0% BUY
2026-08-04$90.85 $67.64 -25.5% BUY
2026-06-23$85.37 $63.93 -25.1% BUY